Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment

Sponsor
Karolinska Institutet (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05826002
Collaborator
Region Stockholm (Other)
385
1
8
24
16

Study Details

Study Description

Brief Summary

In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms. In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms. The participants will be adults with insomnia. The trial will be a 2x2x2 randomized factorial experiment, where the following features/factors will be manipulated: an optimized graphical user interface (yes or no), an adaptive treatment strategy (yes or no), and daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features. The main outcome will be the effect on treatment engagement.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital self-guided psychological intervention for insomnia
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
385 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
A 2x2x2 randomized factorial experiment, where adult participants with insomnia get to use a digital self-guided intervention for insomnia. Three factors/treatment features will be manipulated in the experiment, namely: 1) an optimized graphical user interface (yes or no), 2) an adaptive treatment strategy (yes or no), and 3) daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features.A 2x2x2 randomized factorial experiment, where adult participants with insomnia get to use a digital self-guided intervention for insomnia. Three factors/treatment features will be manipulated in the experiment, namely: 1) an optimized graphical user interface (yes or no), 2) an adaptive treatment strategy (yes or no), and 3) daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features.
Masking:
Single (Participant)
Masking Description:
Participants will be blinded to what condition they are randomized to, and will not receive information concerning what features are being manipulated in the experiment.
Primary Purpose:
Treatment
Official Title:
Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2025
Anticipated Study Completion Date :
Apr 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Digital insomnia intervention

This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (no).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + optimized user interface

This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (no).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + adaptive treatment strategy

This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (no).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy

This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (no).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + daily prompts

This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (yes).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + optimized user interface, daily prompts

This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (yes).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + adaptive treatment strategy, daily prompts

This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (yes).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy, daily prompts

This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (yes).

Behavioral: Digital self-guided psychological intervention for insomnia
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Outcome Measures

Primary Outcome Measures

  1. Engagement with intervention method [Up to 12 months after treatment]

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

  2. Engagement with intervention method [Immediately after treatment (4 weeks after treatment start)]

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

Secondary Outcome Measures

  1. Change in Insomnia symptoms [Change from baseline (right before treatment start) up to 12 months after treatment]

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

  2. Change in Insomnia symptoms [Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)]

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

  3. Change in Depression symptoms [Change from baseline (right before treatment start) up to 12 months after treatment]

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

  4. Change in Depression symptoms [Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)]

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

  5. Change in Anxiety symptoms [Change from baseline (right before treatment start) up to 12 months after treatment]

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

  6. Change in Anxiety symptoms [Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)]

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

  7. Change in Life quality [Change from baseline (right before treatment start) up to 12 months after treatment]

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

  8. Change in Life quality [Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)]

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

  9. Change in Daily function [Change from baseline (right before treatment start) up to 12 months after treatment]

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

  10. Change in Daily function [Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)]

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

  11. Treatment credibility [2 weeks after treatment start (mid-treatment)]

    Credibility/Expectancy Questionnaire (self-rated), score range 0-50, higher is better

  12. Intervention/system usability [2 weeks after treatment start (mid-treatment)]

    System Usability Scale (self-rated), score range 0-100, higher is better

  13. Treatment satisfaction [Immediately after treatment (4 weeks after treatment start)]

    Client Satisfaction Questionnaire-8 (self-rated), score range 8-32, higher is better

Other Outcome Measures

  1. Clinician time [Immediately after treatment (4 weeks after treatment start)]

    Time in minutes the clinician spends on the participant giving guidance through telephone calls and/or written guidance, in minutes, lower is better

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. ≥ 18 years of age.

  2. ≥ 15 points on Insomnia Severity Index.

  3. Insomnia diagnosis, according to criteria in the Diagnostic and Statistical Manual of mental disorders-5 (somatic/psychiatric comorbidity is allowed).

  4. Good understanding of the Swedish language.

  5. No practical obstacles to participate in treatment and assessments.

  6. Daily access to computer/smart-phone/tablet with Internet access.

  7. Can receive phone calls and text messages during the study period.

Exclusion Criteria:
  1. Sleep diseases, such as narcolepsy or sleep apnea.

  2. Somatic or psychiatric illnesses that either are directly contraindicated for the treatment, require other treatment, or entail symptoms/a functional level making it too difficult to participate in the study.

  3. Alcohol/drug abuse, or medication with side effects on sleep (however, sleep medication is allowed).

  4. Working nights or night shifts.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Psychiatry Research Stockholm Sweden

Sponsors and Collaborators

  • Karolinska Institutet
  • Region Stockholm

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martin Kraepelien, Clinical Psychologist, Principal Investigator, PhD, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT05826002
Other Study ID Numbers:
  • 2022-07226-01
First Posted:
Apr 24, 2023
Last Update Posted:
Apr 24, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Martin Kraepelien, Clinical Psychologist, Principal Investigator, PhD, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 24, 2023